Barraclough R, Devereux G, Hendrick D J, Stenton S C
Dept of Respiratory Medicine, Royal Victoria Infirmary, University of Newcastle-upon-Tyne, UK.
Eur Respir J. 2002 Oct;20(4):826-33. doi: 10.1183/09031936.02.00822002.
The authors investigated changes in asthma prevalence and perception of bronchoconstriction over 6 yrs in adults of Newcastle-upon-Tyne. Postal questionnaires were sent to 6,000 subjects aged 20-44 yrs in 1992-1993 and 1998-1999. Random samples of 600 responders had assessments of atopy, airway responsiveness, and their ability to perceive methacholine-induced bronchoconstriction. The prevalences of asthmatic symptoms, physician-diagnosis, and medication use increased by an average of 4.4%, particularly in subjects aged <30 yrs (8.7 versus 2.7). Atopy prevalence increased from 25% to 31% but atopics and nonatopics had similar mean changes in questionnaire data (5.2 versus 3.4). The probability of a positive methacholine test decreased as did the mean methacholine dose/response slope (0.00527 to 0.00379), indicating lower levels of airway responsiveness. This can be largely explained by an increase in use of inhaled corticosteroids (5.0-9.3%). The proportion of subjects perceiving bronchoconstriction during methacholine tests increased from 63 to 77%. The authors conclude that current changes in asthma epidemiology in adults may result from increased awareness of symptoms (and/or an increased willingness to report them), and from an increased willingness of physicians to make the diagnosis and prescribe treatment, not from increased disease prevalence.
作者调查了泰恩河畔纽卡斯尔成年人在6年期间哮喘患病率及支气管收缩感知情况的变化。在1992 - 1993年和1998 - 1999年,向6000名年龄在20 - 44岁的受试者邮寄了调查问卷。对600名应答者的随机样本进行了特应性、气道反应性评估,以及他们对乙酰甲胆碱诱发支气管收缩的感知能力评估。哮喘症状、医生诊断及药物使用的患病率平均增加了4.4%,尤其在年龄小于30岁的受试者中(从2.7%增至8.7%)。特应性患病率从25%增至31%,但特应性和非特应性受试者在问卷数据中的平均变化相似(分别为5.2和3.4)。乙酰甲胆碱试验阳性的概率降低,乙酰甲胆碱剂量/反应平均斜率也降低(从0.00527降至0.00379),表明气道反应性水平降低。这在很大程度上可由吸入性糖皮质激素使用增加(从5.0%增至9.3%)来解释。在乙酰甲胆碱试验期间感知到支气管收缩的受试者比例从63%增至77%。作者得出结论,目前成年人哮喘流行病学的变化可能是由于对症状的认识增加(和/或报告症状的意愿增加),以及医生做出诊断和开处方治疗的意愿增加,而非疾病患病率增加所致。